focus -WSS

focus

author：Wikipedia 2025-09-29 20:53:21 - browse：9

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Election results set back Medicaid expansion plans

focus

WSS

Tori Bowie and the unacceptable rates of Black maternal death

Hollywood unions extend contract negotiations for actors

Restaurant meals are packed with calories, and we still keep eating them

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Google's generative AI to analyze medical images — and talk to docs

Cancer drug shortages should be causing more outrage

entertainment

focus

explore

Medical records are filled with copy

Supreme Court strikes down use of affirmative action

Moonlake's readout produced a cash windfall. Risks remain

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Moonlake's readout produced a cash windfall. Risks remain

Election results set back Medicaid expansion plans

The high cost of giving birth even with insurance

The cancer drug shortage isn’t new — and neither are the solutions

In age of alternative facts, a scholarly course on calling out crap

Doctors push to include dialysis machines in emergency stockpile

hotspot

Continuity nursing helped my family in our darkest PICU moments

Supreme Court strikes down use of affirmative action

In age of alternative facts, a scholarly course on calling out crap

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medical leaders decry Supreme Court decision on affirmative action

Cancer drug shortages should be causing more outrage

leisure time

explore

focus

explore